MARZOLA, Erika
 Distribuzione geografica
Continente #
NA - Nord America 5.395
AS - Asia 2.739
EU - Europa 1.785
SA - Sud America 392
Continente sconosciuto - Info sul continente non disponibili 137
AF - Africa 71
OC - Oceania 10
Totale 10.529
Nazione #
US - Stati Uniti d'America 5.259
SG - Singapore 1.054
CN - Cina 619
IT - Italia 515
VN - Vietnam 306
BR - Brasile 272
DE - Germania 262
HK - Hong Kong 215
GB - Regno Unito 174
PL - Polonia 165
UA - Ucraina 161
BD - Bangladesh 122
FI - Finlandia 116
TR - Turchia 112
FR - Francia 102
CA - Canada 81
SE - Svezia 76
JP - Giappone 67
IN - India 59
RU - Federazione Russa 56
ID - Indonesia 47
AR - Argentina 40
NL - Olanda 37
MX - Messico 36
ZA - Sudafrica 31
BE - Belgio 28
CO - Colombia 26
PK - Pakistan 21
IQ - Iraq 20
LT - Lituania 17
ES - Italia 16
EC - Ecuador 15
IR - Iran 12
SA - Arabia Saudita 12
AT - Austria 11
IE - Irlanda 11
PH - Filippine 11
MY - Malesia 10
UY - Uruguay 9
CL - Cile 8
TN - Tunisia 8
UZ - Uzbekistan 8
AU - Australia 7
DZ - Algeria 7
PY - Paraguay 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
IL - Israele 6
JO - Giordania 6
MA - Marocco 6
AL - Albania 5
BG - Bulgaria 5
PE - Perù 5
RO - Romania 5
KE - Kenya 4
KZ - Kazakistan 4
BO - Bolivia 3
GR - Grecia 3
HU - Ungheria 3
KR - Corea 3
LB - Libano 3
NI - Nicaragua 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AZ - Azerbaigian 2
CH - Svizzera 2
ET - Etiopia 2
HN - Honduras 2
NA - Namibia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
SN - Senegal 2
SV - El Salvador 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
Totale 10.383
Città #
Ashburn 699
Singapore 681
Fairfield 423
San Jose 405
Woodbridge 405
Ann Arbor 238
Beijing 233
Houston 223
Santa Clara 220
Hong Kong 207
Seattle 186
Jacksonville 169
Chandler 166
Ferrara 166
Warsaw 159
Cambridge 149
Wilmington 147
New York 145
Council Bluffs 131
Ho Chi Minh City 101
Los Angeles 98
Munich 89
Dallas 81
Milan 77
Tokyo 66
Hanoi 62
Izmir 60
Princeton 52
Lauterbourg 50
Helsinki 48
Dearborn 47
Nanjing 47
Addison 44
Shanghai 40
San Diego 38
Jakarta 33
The Dalles 32
Boardman 31
Toronto 31
Turku 31
São Paulo 30
London 27
Atlanta 26
Bologna 26
Brussels 26
Frankfurt am Main 25
Orem 23
Mexico City 22
Buffalo 21
Chicago 21
Montreal 21
Johannesburg 20
Brooklyn 19
Falkenstein 19
Phoenix 18
Auburn Hills 16
Hefei 16
Redwood City 16
Denver 15
Manchester 15
Nanchang 15
Turin 15
Haiphong 14
Rome 13
Boston 12
Bremen 12
San Mateo 12
Tianjin 12
Ferrara di Monte Baldo 11
Medellín 11
San Francisco 11
Shenyang 11
Stockholm 11
Washington 11
Biên Hòa 10
Changsha 10
Charlotte 10
Da Nang 10
Dublin 10
Hebei 10
Lahore 10
Moscow 10
Mountain View 10
Newark 10
Philadelphia 10
Chennai 9
Florence 9
Istanbul 9
Montevideo 9
Padova 9
Poplar 9
Jinan 8
New Delhi 8
Norwalk 8
Amsterdam 7
Augusta 7
Baghdad 7
Bexley 7
Columbus 7
Jeddah 7
Totale 7.133
Nome #
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 295
Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten 293
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 291
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 279
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 267
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 249
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 249
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 247
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 245
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 245
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 245
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 235
Physicochemical stability of cabazitaxel and docetaxel solutions 228
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 228
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 221
Pharmacological characterization of tachykinin tetrabranched derivatives 220
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 213
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 213
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 213
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 204
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 203
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 202
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 200
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 199
How terminal protection affects the chemical and biological properties of the antimicrobial calcitermin 199
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 198
Structure-activity study at positions 3 and 4 of human neuropeptide S. 197
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 196
Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans 190
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 182
Structure-activity relationship study on human urotensin II 179
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 178
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 177
Novel Mixed NOP/Opioid Receptor Peptide Agonists 176
Synthesis of 2,6-Dimethyltyrosine-Like Amino Acids through Pinacolinamide-Enabled C-H Dimethylation of 4-Dibenzylamino Phenylalanine 176
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): Identification of a partial agonist of the UT receptor 173
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 172
Thermodynamic and spectroscopic investigation on the role of Met residues in CuII binding to the non-octarepeat site of the human prion protein 169
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 166
Synthesis and antimicrobial activity of dermaseptin S1 analogues 163
CCR4+ CD8+ T cells clonally expand to differentiated effectors in murine psoriasis and in human psoriatic arthritis 151
Impact of C- and N-terminal protection on the stability, metal chelation and antimicrobial properties of calcitermin 150
Role of 2′,6′-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds 149
A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study 146
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 137
The N-terminal domain of Helicobacter pylori's Hpn protein: The role of multiple histidine residues 129
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays 128
Manganese complexes for multimodal PET/MRI imaging: progress of METRICS project 122
METRICS project: Synthesis of Manganese Complexes as potential PET/MRI Agents 115
Positively charged residues play a significant role in enhancing the antibacterial activity of calcitermin 113
Synthesis and characterization of manganese dithiocarbamate complexes: New evidence of dioxygen activation 113
Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acid 104
null 94
Production and Characterization of Semi-Solid Formulations for the Delivery of the Cosmetic Peptide Palmitoyl-GHK 89
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands 88
Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity 84
null 42
Totale 10.529
Categoria #
all - tutte 47.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 619
Totale 48.206


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022567 0 53 47 42 33 14 35 37 37 51 55 163
2022/2023485 58 31 26 54 62 50 55 50 46 2 29 22
2023/2024396 31 41 26 10 16 90 17 46 10 11 18 80
2024/20251.453 35 29 146 62 175 142 28 71 255 129 188 193
2025/20264.337 460 158 329 481 624 322 532 229 352 456 246 148
2026/2027317 160 157 0 0 0 0 0 0 0 0 0 0
Totale 10.529